BriaCell Therapeutics Corp.
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
News 2026-05-26
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
News release - English.pdf
Results 2026-05-22
BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT™ at ASCO 2026
News release - English.pdf
News 2026-05-15
BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™
News release - English.pdf
News 2026-05-14
BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+™ for Prostate Cancer
News release - English.pdf
News 2026-05-13
BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
News release - English.pdf
Results 2026-05-12
BriaCell Phase 3 Bria-IMT Study Enrollment Surpasses 230 Patients
News release - English.pdf
News 2026-05-07
BriaCell Adds NYU Langone Health's Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
News release - English.pdf
News 2026-05-06
BriaCell Receives FDA Clearance to Initiate Bria-BRES+ Clinical Study in Breast Cancer
News release - English.pdf
News 2026-04-27
BriaCell Announces Six Clinical Data Presentations at ASCO 2026
News release - English.pdf
News 2026-04-21
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models
News release - English.pdf
News 2026-04-20
BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting
News release - English.pdf
Ownership 2026-03-31
Early warning report.pdf
Transactions 2026-03-31 M&A
BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License
News release - English.pdf
News 2026-03-18
BriaCell to Present Positive Clinical Data for Bria-IMT and Preclinical Data for Next Generation Bria-OTS+ Personalized Immunotherapy at the 2026 AACR Conference
News release - English.pdf
Results 2026-03-10 Financials
Interim MD&A - English.pdf
Results 2026-03-10 Financials
Interim financial statements/report – English.pdf
News 2026-03-10
BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting
News release - English.pdf
Transactions 2026-02-18 M&A
BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License
News release - English.pdf
News 2026-02-17
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
News release - English.pdf
News 2026-02-12
Other.pdf
News 2026-02-12
Other.pdf
News 2026-02-12
Other.pdf
News 2026-01-28
BriaCell Patients' Images Show Regression and Resolution of Metastatized Tumors and Immune Activation
News release - English.pdf
Results 2026-01-27
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients
News release - English.pdf
News 2026-01-16
Offering material - English.pdf
News 2026-01-16
Other.pdf
News 2026-01-16
Offering material - English.pdf
News 2026-01-16
Offering material - English.pdf
Transactions 2026-01-15 Financing
BriaCell Therapeutics Announces Closing of US$30 million Public Offering
News release - English.pdf
Transactions 2026-01-14 Financing
BriaCell Therapeutics Announces Pricing of $30 million Public Offering
News release - English.pdf
Results 2026-01-13
BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Patient
News release - English.pdf
News 2025-12-18
"Eleven clinical trials that will shape medicine in 2026" – BriaCell Phase 3 Trial Featured in Nature Medicine
News release - English.pdf
Results 2025-12-11 Financials
Interim MD&A - English.pdf
Results 2025-12-11 Financials
Interim financial statements/report – English.pdf
Results 2025-12-10
BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025
News release - English.pdf
Results 2025-12-09
BriaCell's Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout
News release - English.pdf
News 2025-12-02
BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025
News release - English.pdf
News 2025-11-25
BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025
News release - English.pdf
News 2025-11-20
BriaCell and Receptor.Al to Collaborate on AI Driven Small Molecule Cancer Therapeutics
News release - English.pdf
News 2025-11-18
BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025
News release - English.pdf
News 2025-11-07
News release - English.pdf
News 2025-11-04
News release - English.pdf
News 2025-10-22
News release - English.pdf
News 2025-10-21
News release - English.pdf
News 2025-10-21
News release - English.pdf
News 2025-10-20
News release - English.pdf
Results 2025-10-15 Financials
Annual report on form 10-K - English.pdf
Results 2025-10-15 Financials
Annual MD&A - English.pdf
Results 2025-10-15 Financials
Audited annual financial statements – English.pdf
News 2025-10-13
News release - English.pdf
News 2025-10-03
News release - English.pdf
News 2025-08-27
Material change report - English.pdf
News 2025-08-26
News release - English.pdf
News 2025-08-25
News release - English.pdf
News 2025-08-21
News release - English.pdf
News 2025-08-13
News release - English.pdf
News 2025-08-06
News release - English.pdf
News 2025-07-31
News release - English.pdf
News 2025-07-30
News release - English.pdf
News 2025-07-29
News release - English.pdf
News 2025-07-25
News release - English.pdf
News 2025-07-24
Material change report - English.pdf
News 2025-07-16
Offering material - English.pdf
News 2025-07-16
Offering material - English.pdf
News 2025-07-16
Offering material - English.pdf
News 2025-07-16
Offering material - English.pdf
News 2025-07-16
Other.pdf
News 2025-07-16
News release - English.pdf
News 2025-07-15
News release - English.pdf
News 2025-07-15
News release - English.pdf
News 2025-07-11
News release - English.pdf
News 2025-07-10
News release - English.pdf
News 2025-07-09
News release - English.pdf
News 2025-07-08
News release - English.pdf
News 2025-07-02
News release - English.pdf
News 2025-06-24
News release - English.pdf
Results 2025-06-16 Financials
Interim MD&A - English.pdf
Results 2025-06-16 Financials
Interim financial statements/report – English.pdf
News 2025-06-04
News release - English.pdf
News 2025-06-02
News release - English.pdf